Keith Speights

Keith Speights

TMFFishBiz

Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries.

Recent articles

2 jigsaw puzzle pieces

Why Endo International and BioSpecifics Technologies Stocks Soared Today

Investors are fired up about Endo's planned acquisition of BioSpecifics.


COVID-19 saliva test

Why OraSure Technologies Stock Is Soaring Today

The FDA granted Emergency Use Authorization for the company's at-home saliva collection device for coronavirus testing.


Two scientists working in a lab

Better Buy: Amgen vs. Bristol Myers Squibb

Here's how these two big drugmakers stack up against each other in several key categories.


Gloved hands holding vaccine bottle and syringe

Better Coronavirus Stock: Inovio Pharmaceuticals or VBI Vaccines?

Neither biotech is in the front of the pack in developing a COVID-19 vaccine.


Timeline with green pushpin on 2025

Where Will Novavax Be in 5 Years?

This small biotech might be a lot bigger by 2025.

Woman holding tablet with 3 stacks of coins

3 Dividend Stocks I'd Buy Right Now

Solid dividends plus strong growth prospects add up to great stocks to buy.


Woman extending arms with wooden line trending up

3 Stocks Poised to Be Surefire Winners in the New Bull Market

Each of them benefits from unstoppable trends.


Physician holding a vaccine shot

Better Coronavirus Stock: Moderna vs. Sorrento Therapeutics

Both biotechs have promising COVID-19 programs. But one is a much better pick at this point.


Face masks on top of money

3 Pandemic Stocks That Could Make You Rich

These companies have benefited significantly from the COVID-19 pandemic already, and it looks like they have much more room to grow.


Businessman with thumb up

Why Aldeyra Therapeutics Stock Soared Today

An analyst is very bullish about the biotech stock.

Cannabis leaf on $100 bill

Better Marijuana Stock: Curaleaf vs. Canopy Growth

Which stock wins in a matchup between two of the biggest cannabis companies in North America?


intuitive-da-vinci-or-staff-with-patient-cart-hi-res

The Good News Buried in the Bad News of Intuitive Surgical's Q3 Update

The COVID-19 pandemic continued to weigh on the robotic surgical systems maker in Q3, but there were some bright spots.


Man with drawings of light bulbs

Buying These 3 Popular Robinhood Stocks Would Be a Really Smart Move Right Now

Following the crowd is a great idea with these three top stocks.


Physician with COVID-19 patient wearing mask

Why Eiger BioPharmaceuticals Stock Skyrocketed Today

Investors were excited about the company's positive results from a COVID-19 clinical study


Scientists looking through microscopes

Why Replimune Stock Is Soaring Today

The company plans to present encouraging early-stage clinical data at a major conference next month.

2 checked boxes with one box unchecked

2 Popular Coronavirus Stocks on Robinhood to Buy -- and 1 to Avoid

The timing is right for two popular Robinhood stocks with promising COVID-19 programs.


Man putting ballot in box with flag in background

This Marijuana Stock Might Just Be the Biggest Winner on Election Day

It's not on any ballot, but it stands to benefit in a big way depending on what voters decide on Nov. 3.


Gloved hand pressing pause button

Late-Stage Study of Lilly's COVID-19 Antibody Therapy Paused: Buy the Stock on the Dip?

There's more good news than bad for the big drugmaker.


Gloved hands holding 2 COVID vaccine bottles

Here Are the Only 2 Coronavirus Vaccines That Could Meet the FDA's Authorization Guidelines by Year-End

It's a process of elimination.


Scientist holding vaccine bottle and syringe

Why Novavax Stock Is Jumping Today

The biotech had some news about its flu vaccine candidate NanoFlu and benefited from a rival's COVID-19 vaccine trial pause.